ABEOW | tickerfilter.com

Fundamental analysis

Profitability 0%

Dept financing 0%

Liquidity 0%

Performance 0%

Performance

5 Days

0 0%

1 Month

0 0%

3 Months

0 0%

6 Months

0 0%

1 Year

0 0%

2 Year

0 0%

Key data

Stock price

$0.07

P/E Ratio

N/A

DAY RANGE

$0.07 - $0.07

EPS

$0.00

52 WEEK RANGE

$2.46 - $16.00

52 WEEK CHANGE

-$66.35

MARKET CAP

76.762 M

YIELD

N/A

SHARES OUTSTANDING

0.000

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

N/A

BETA

0.00

PUBLIC FLOAT

AVERAGE 10 VOLUME

$116

AVERAGE 30 VOLUME

$999

Company detail

CEO: Joao Siffert
Region: US
Website: http://www.abeonatherapeutics.com
Employees: 0
IPO year: -

Issue type:
Market: NASDAQ
Industry: Pharmaceuticals: Generic
Sector: Health Technology

Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB); ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA) and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in New York, NY.

ABEOW - Abeona Therapeutics Inc Warrants 2015-19.12.19 on Shs